HPV-SAVE_Merck_Sub-Study for Preventing Recurrence of HSIL

Clinical trial NCT03947775 · UNKNOWN

Trial details

NCT number: NCT03947775
Sponsor: University Health Network, Toronto
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Anal Intraepithelial Neoplasia Anal Cancer Human Papilloma Virus

Start date: 2022-09-01
Primary completion: 2026-03-01
Enrollment: 228

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.